1NKEMIA Logo

1NKEMIA

IKM | BME Growth

Overview

Corporate Details

ISIN(s):
ES0156303002
LEI:
959800QRRHKJ6C8MW495
Country:
Spain
Address:
C/Alvarez de Castro 63, 08100 Mollet del Vallès
Sector:
Health Care
Industry:
Biotechnology

Description

1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-26 Björn Zethraeus Other Other 6,646 66,460,000.00 SEK
2025-05-24 Anders Nilsson Other Other 10,000 326,900.00 SEK
2025-05-23 marius balger Other Sell 45,000 534,150.00 SEK
2025-05-23 Todd Heringer Other Other 150,000 N/A
2025-05-22 Klaudija Cavala Other Other 100,000 22,000.00 SEK
2025-05-20 Gionata La Torre Other Buy 31,182 951,051.00 SEK
2025-05-20 Karl-Emil Engström Other Sell 5,000 279,350.00 SEK
2025-05-20 Christina Thérèse Hersch Fagerberg Other Sell 1,000 55,870.00 SEK
2025-05-20 Gionata La Torre Other Buy 31,182 N/A
2025-05-19 Erik Gjötterberg Other Other 15,000 311,550.00 SEK

Peer Companies

Company Country Ticker View
Gentian Diagnostics ASA Logo Gentian Diagnostics ASA Norway GENT
Genus PLC Logo Genus PLC United Kingdom GNS
Grace Breeding Ltd. Logo Grace Breeding Ltd. Israel GRAC
Group 107 Ltd. Logo Group 107 Ltd. Israel G107
Guard Therapeutics International AB Logo Guard Therapeutics International AB Sweden GUARD
Gubra A/S Logo Gubra A/S Denmark GUBRA
Hadasit Bio Holding Ltd. Logo Hadasit Bio Holding Ltd. Israel HDST-M
Hansa Biopharma Logo Hansa Biopharma Sweden HNSA
HEMOGENYX PHARMACEUTICALS PLC Logo HEMOGENYX PHARMACEUTICALS PLC United Kingdom HEMO
Herantis Pharma Oyj Logo Herantis Pharma Oyj Finland HRTIS